The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin

Not Applicable

• Conditions: Kidney Failure; Inflammation

• Registration Number: NCT03845530
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

The aim of this study is to determine the levels of alpha-defensin throughout the hemodialysis course compared to the levels at the end of a course of peritoneal dialysis, as a reflection of the inflammatory burden.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-02
• Study First Submitted: 2019-02-18
• Study First Submitted QC: 2019-02-18
• Last Update Submitted: 2019-02-18
• Study First Posted: 2019-02-19
• Last Update Posted: 2019-02-19
• Study Start: 2019-03
• Primary Completion: 2020-03
• Study Completion: 2020-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Kidney failure patients undergoing hemodialysis or peritoneal dialysis

Exclusion Criteria

• Active inflammatory or infectious disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Alpha-Defensin Levels	One year	Alpha-defensin levels will be compared between the two arms

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel